11 September 2017

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

11 September 2017 | n=16

  1. Khan S, Telwatte S, Trapecar M, Yukl S, et al.
    Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure.
    AIDS Res Hum Retroviruses 2017.

  2. Kieffer C, Ladinsky MS, Bjorkman PJ.
    Multiscale imaging of HIV-1 transmission in humanized mice.
    AIDS Res Hum Retroviruses 2017.

  3. Trapecar M, Khan S, Roan N, Chen TH, et al.
    An Optimized and Validated Method for Isolation and Characterization of Lymphocytes from HIV+ Human Gut Biopsies.
    AIDS Res Hum Retroviruses 2017.

  4. Tram KH, Mwangwa F, Atukunda M, Owaraganise A, et al.
    Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.
    J Acquir Immune Defic Syndr 2017.

  5. Rice WS, Burnham K, Mugavero MJ, Raper JL, et al.
    Association between Internalized HIV-related Stigma and HIV Care Visit Adherence.
    J Acquir Immune Defic Syndr 2017.

  6. Moore DM, Cui Z, Lachowsky NJ, Rich AJ, et al.
    Increasing HIV treatment optimism but no changes in HIV risk behaviour among men who have sex with men (MSM) in Vancouver, Canada.
    J Acquir Immune Defic Syndr 2017.

  7. Cavaretto LDSP, Motta-Castro ARC, Teles SA, de Souza FQ, et al.
    Epidemiological and molecular analysis of hepatitis B virus infection in manicurists in Central Brazil.
    J Med Virol 2017.

  8. Leitman EM, Willberg CB, Tsai MH, Chen H, et al.
    J Virol 2017.

  9. De Boer RJ, Perelson AS.
    How germinal centers evolve broadly neutralizing antibodies: the breadth of the follicular helper T cell response.
    J Virol 2017.

  10. Rizk MG, Basler CF, Guatelli J.
    Cooperation of the Ebola proteins VP40 and GP1,2 with BST2 to activate NF-kappabeta independently of virus-like particle trapping.
    J Virol 2017.

  11. Sullivan JT, Sulli C, Nilo A, Yasmeen A, et al.
    High-throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers.
    J Virol 2017.

  12. Sax PE, Pozniak A, Montes ML, Koenig E, et al.
    Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-infer
    Lancet 2017.

  13. Boffito M, Venter F.
    The triumph of HIV treatment: another new antiretroviral.
    Lancet 2017.

  14. Gallant J, Lazzarin A, Mills A, Orkin C, et al.
    Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.
    Lancet 2017.

  15. Hormi M, Khourouj VG, Pommelet V, Jeljeli M, et al.
    Performance of the QuantiFERON-TB Gold Assay Among HIV-infected Children with Active Tuberculosis in France.
    Pediatr Infect Dis J 2017.

  16. Panda S, Swaminathan S, Hyder KA, Christophel EM, et al.
    Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations.
    BMJ 2017;358:j3545.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

21 May 2018

14 May 2018

07 May 2018

30 April 2018

23 April 2018

11 September 2017

Multidisciplinary Journal Club

  1. Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, et al.
    Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    J Clin Oncol. 2017;35:2288-2298.

  2. Kulik L, Heimbach JK, Zaiem F, Almasri J, et al.
    Therapies for Patients with Hepatocellular Carcinoma Awaiting for Liver Transplantation: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29485.

  3. Govindan R, Szczesna A, Ahn MJ, Schneider CP, et al.
    Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2017 Aug 30:JCO2016717629. doi: 10.1200/JCO.2016.71.7629.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016